跳至主要内容
临床试验/NCT02471781
NCT02471781Approved For Marketing不适用

Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study

Cook Group Incorporated15 个研究点 分布在 1 个国家开始时间: 2015年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
Approved For Marketing
试验地点
15

研究概览

简要总结

The Zenith TX2 Low Profile TAA Endovascular Graft extended study is to collect confirmatory safety and effectiveness data. The Zenith TX2 Low Profile TAA Endovascular Graft is indicated for the treatment of patients with a descending thoracic aortic aneurysm or penetrating ulcer and has an anatomy suitable for repair.

研究设计

研究类型
Expanded Access

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meets one of the following
  • Descending thoracic aneurysm with diameter ≥ 5.0 cm
  • Descending thoracic aneurysm with a history of growth ≥ 0.5 cm per year
  • Descending thoracic degenerative or atherosclerotic ulcer ≥ 10 mm in depth and 20 mm in diameter

排除标准

  • Life expectancy less than 2 years
  • Pregnant of breastfeeding or planning on becoming pregnant within 60 months
  • Unwilling to comply with the follow-up schedule
  • Less than 30 days beyond primary endpoint for other investigative drug or device study
  • Receiving home oxygen
  • Myocardial infarction within the last 3 months
  • Stroke within the last 3 months
  • Diagnosed or suspected congenital degenerative collagen disease
  • Systemic infection
  • Bleeding diathesis, uncorrectable coagulopathy, or refuses blood transfusion
  • Allergy to polyester, polypropylene, nitinol, or gold
  • Previous placement of a thoracic endovascular graft
  • Prior open repair involving the descending thoracic aorta

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验